glp 1 afib New research presented at #HRS2026 finds #GLP1 medications may reduce the risk of #AFib — independent of weight loss. The findings suggest these therapies may influence heart rhythm through mechanisms beyond weight Impact of GLP-1 receptor agonists

You are responsible for understanding and complying with all import/export regulations and customs requirements

Higher Risk Health Conditions for Women Liver disease Women develop alcohol-associated hepatitis faster than men consuming the same amount Brain damage Alcohol misuse produces brain damage more quickly in women, including greater reductions in memory-related brain structures Heart disease Women are more susceptible to alcohol-related cardiac damage, even with lower lifetime consumption Breast cancer 1 drink/day raises risk by 59%

GLP-1 agonists are most often used by people with type 2 diabetes to manage blood sugar levels, but in recent years, theyve become a top treatment choice for people with overweight or obesity for weight management

She was perpetually discouraged by her inability to make meaningful lifestyle changes that translated to changes in weight and therefore, any medication reduction or improvement in outcomes